Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Impedimed Limited ( (AU:IPD) ) has provided an announcement.
ImpediMed Limited, a company listed on the Australian Securities Exchange, has released a presentation to be delivered to investors and analysts. This announcement signifies the company’s ongoing engagement with its stakeholders and may provide insights into its financial performance and strategic direction for the fourth quarter of fiscal year 2025.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.20 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
Average Trading Volume: 2,737,954
Technical Sentiment Signal: Hold
Current Market Cap: A$105.4M
Find detailed analytics on IPD stock on TipRanks’ Stock Analysis page.